Results 41 to 50 of about 697,686 (293)

Randomised Trial Determining Acute Effects on Intracranial Pressure of Drugs Utilised in Idiopathic Intracranial Hypertension

open access: yes, 2022
Limited data exists to guide treatment of idiopathic intracranial hypertension (IIH). We examined the ability of drugs used in IIH to lower intracranial pressure (ICP)
Alex Sinclair; James Mitchell; Susan Mollan; Andreas Yiangou; Hannah Lyons; George Tsermoulas; Kristian Brock
core  

Effects of Add‐On Icosapent Ethyl With Standard Treatment on Functional Outcomes and Inflammatory Biomarkers in Acute Ischemic Stroke: A Blinded Randomized Controlled Trial

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Ischemic stroke, a major cause of mortality and long‐term disability, results from the abrupt cessation of cerebral blood flow due to vascular occlusion or rupture. Icosapent Ethyl (EPA‐EE), approved for hypertriglyceridemia, has anti‐inflammatory and antithrombotic properties that may lessen ischemic damage.
Mitra Mahmoudi Meymand   +5 more
wiley   +1 more source

Intracranial hypertension associated with topical tretinoin use

open access: yesAmerican Journal of Ophthalmology Case Reports, 2021
Purpose: To report cross-reactivity between topical vitamin A derivatives and tetracycline-class antibiotics. Observations: A 19-year old woman with a remote history of resolved secondary intracranial hypertension due to minocycline use developed ...
Suzie Gasparian   +2 more
doaj   +1 more source

Dural Arteriovenous Fistulas Presenting as Idiopathic Intracranial Hypertension

open access: yes, 2022
Dural arteriovenous fistula (dAVF) and idiopathic intracranial hypertension (IIH) may present similarly.
Roma N. Ahuja; Menachem Weiss; Martha Schatz
core  

Integrating Time‐Adjusted Imaging Instability Into Functional Outcome Prediction After Intracerebral Hemorrhage: Development and Validation of the HAGIV Score

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Early risk stratification may support clinical decision‐making in spontaneous intracerebral hemorrhage (ICH). We aimed to develop and internally validate HAGIV, a score integrating frequency of imaging markers (FIM), a time‐adjusted non‐contrast computed tomography (CT) metric of hematoma expansion, with established predictors for 90‐
Lei Song   +10 more
wiley   +1 more source

Blood RNA Biomarker Signatures for Early Diagnosis and Prognosis in Ischemic and Hemorrhagic Stroke: The IBIS‐CT1 Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the expression of nine blood RNA biomarkers in a clinical trial based on genes previously identified in an experimental monkey model of stroke for diagnosis feasibility and prognostication. Methods IBIS‐CT1 was a prospective longitudinal study enrolling patients with ischemic stroke (IS) or intracerebral hemorrhage (ICH ...
Salomé Retailleau   +11 more
wiley   +1 more source

Idiopathic Intracranial Hypertension (IIH) After Spinal Surgery Due to Spondylitis Tuberculosis

open access: yesIndonesian Journal of Anesthesiology and Reanimation (IJAR)
Introduction: Idiopathic intracranial hypertension (IIH) is a rare syndrome with an unclear etiology but causes clinically increased intracranial pressure (ICP).
Akhyar Nur Uhud   +2 more
doaj   +1 more source

Intracranial Hypertension in Children without Papilledema

open access: yesPediatric Neurology Briefs, 2015
Researchers at Nationwide Children's Memorial Hospital studied the frequency of intracranial hypertension without papilledema in children followed in a multispecialty pediatric intracranial hypertension clinic.
Ana B. Chelse, Leon G. Epstein
doaj   +1 more source

Dural Arteriovenous Fistula at the Cause of Intracranial Hypertension

open access: yes, 2023
Dural arteriovenous fistula (DAVF) is an abnormal shunt between the arterial and venous systems located within the dura. Presenting symptoms of DAVF are variable and can develop intracranial hypertension in about 8% of that.
Kwang-Dong Choi; Hyun Sung Kim; Yu Jin Lee; Sol Rim Choi; Suk-Min Lee; Eun Hye Oh; Seo Young Choi; Jae-Hwan Choi
core  

Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking ...
Osman Corbali   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy